Aarti Drugs
AARTIDRUGS •NSE

Aarti Drugs

₹484.50-14.40 (2.89%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
481.35
Today’s high
503.70
52 week low
318.95
52 week high
527.50
Open price
500.00
Previous close
498.90
Live volume
2,92,093
Lower circuit
399.15
Upper circuit
598.65

Fundamentals

Market Cap
₹4,558Cr
ROE
13.61%
P/E Ratio(TTM)
19.93
EPS(TTM)
25.06
P/B Ratio
2.71
Dividend Yield
0.40%
Industry P/E
40.13
Book Value
184.24
Debt to Equity
0.37
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
SEP '26
₹829Cr
+17.79%
₹82.77Cr
+65.11%
02505007501k
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue growthValue
1Y (TTM)+27%
3Y CAGR-2%
Profit growthValue
1Y (TTM)+83%
3Y CAGR+5%

About

Established in 1984, Aarti Drugs Limited is a prominent player in the pharmaceutical industry, well-positioned for future market growth. Its vision is to become the first-choice vendor for bulk drugs by providing customized solutions and services to meet the changing requirements of customers. The company's mission is to seek global market leadership and strive for excellence in customer service, quality, and R&D. It specializes in manufacturing active pharmaceutical ingredients (APIs), specialty chemicals, and intermediates across various therapeutic categories like antibiotics and anti-diabetics. Through its wholly-owned subsidiary, Pinnacle Life Sciences Private Limited, the company also manufactures advanced formulations, playing a pivotal role in its revenue generation. Aarti Drugs is one of the world's leading producers of Metformin and the largest producer of Metronidazole in India, showcasing its market leadership.;
CEO/MD
Rashesh C Gogri
Founded in
1984
NSE symbol
AARTIDRUGS
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Mutual Funds Invested (3)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹3,856.00
+5.70 (0.15%)
L
    H
    17,611.5020.494.02
    Natco PharmaNATCOPHARM
    ₹814.30
    -7.65 (0.93%)
    L
      H
      16,115.2019.431.46
      ₹2,029.10
      -55.50 (2.66%)
      L
        H
        15,851.4822.644.06
        ₹6,167.50
        +54.50 (0.89%)
        L
          H
          15,301.1386.0917.41
          Livesquawk •
          Aarti Drugs lowered its FY27 volume growth guidance to 5-10% from 15%. The cut follows customers reducing purchases and avoiding stockpiling due to rising API prices.
          Livesquawk •
          Aarti Drugs reported Q2 revenue of ₹7.1B, up from ₹5.8B year-on-year. The higher revenue indicates a strong growth quarter for the company.
          2026
          3
          Nov
          Quarterly & Annual Result
          Release date
          31
          Jul
          Quarterly Result
          Release date
          15
          May
          Quarterly & Annual Result
          Release date

          9
          Feb
          Dividend
          Ex date
          ₹2.00
          per share

          For each share you hold, you will receive ₹2.00
          Dividend amount₹2.00 per share
          Dividend TypeInterim
          Ex Date9 Feb ‘26
          Record Date9 Feb ‘26
          Announcement date3 Feb ‘26

          3
          Feb
          Dividend
          Announced
          ₹2.00
          per share

          For each share you hold, you will receive ₹2.00
          Dividend amount₹2.00 per share
          Dividend TypeInterim
          Ex Date9 Feb ‘26
          Record Date9 Feb ‘26
          Announcement date3 Feb ‘26
          3
          Feb
          Quarterly & Annual Result
          Release date
          2025
          7
          Nov
          Quarterly & Annual Result
          Release date
          18
          Jul
          Quarterly & Annual Result
          Release date

          4
          Feb
          Dividend
          Ex date
          ₹1.00
          per share

          For each share you hold, you will receive ₹1.00
          Dividend amount₹1.00 per share
          Dividend TypeInterim
          Ex Date4 Feb ‘25
          Record Date4 Feb ‘25
          Announcement date29 Jan ‘25

          29
          Jan
          Dividend
          Announced
          ₹1.00
          per share

          For each share you hold, you will receive ₹1.00
          Dividend amount₹1.00 per share
          Dividend TypeInterim
          Ex Date4 Feb ‘25
          Record Date4 Feb ‘25
          Announcement date29 Jan ‘25
          Events calendar
          View upcoming events in other stocks